A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Novel Intravenous Formulation of Meloxicam (QP001) in Healthy Chinese Subjects

A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Novel Intravenous Formulation of Meloxicam (QP001) in Healthy Chinese Subjects

Junlong Ma,1,2,* Jie Huang,1,* Chan Zou,1 Qian Wu,1 Jinlian Xie,1 Xingfei Zhang,1 Xiaoyan Yang,1 Shuang Yang,1 Ziteng Wu,3 Yan Jiang,3 Sen Yu,3 Xuqing Zhang,4 Guoping Yang,1,5 Mingyuan Li1 1The Third Xiangya Hospital, Central South University, Changsha, Hunan, 410013, People’s Republ...

Full description

Bibliographic Details
Main Authors: Ma J, Huang J, Zou C, Wu Q, Xie J, Zhang X, Yang X, Yang S, Wu Z, Jiang Y, Yu S, Yang G, Li M
Format: Article
Language:English
Published: Dove Medical Press 2023-08-01
Series:Drug Design, Development and Therapy
Subjects:
meloxicam
phase i trial
pharmacokinetic
safety
novel formulation
Online Access:https://www.dovepress.com/a-phase-i-study-to-evaluate-the-safety-tolerability-and-pharmacokine-2-peer-reviewed-fulltext-article-DDDT

Internet

https://www.dovepress.com/a-phase-i-study-to-evaluate-the-safety-tolerability-and-pharmacokine-2-peer-reviewed-fulltext-article-DDDT

Similar Items